Project Description

IBM

What is Dayan Group doing for IBM Company?

Brief

Early detection aims to identify consequential cancer or precancerous change at the earliest time point at which intervention could improve survival or reduce morbidity. Consequential disease will cause mortality or substantial morbidity within the individual’s expected remaining life span.

Deliverables

In this project, measures are being taken in the field of early cancer detection so that those who are prone to cancer diseases can be diagnosed using it.
In this project, there is a contract between the large IBM company and Salamat Yar Behesht Dayan for research and development and completing the technical knowledge created in this company to advance and commercialize the mentioned project.

  • Early detection of cancer cells

  • Can use for different Cancers

R&D Stage
End Product
Market Share

Ready to Talk?

DO YOU HAVE A BIG IDEA WE CAN HELP WITH?

Contact Us